glp 1 agonist vision loss A potentially blinding condition is a very rare side effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Frontiers | Unlocking the potential

Valproic acid is FDA approved for use as an antiepileptic, for the prevention of migraines, and for manic or mixed episodes associated with bipolar disorder

Fernandez-Vazquez, G

Abstract Growth hormone (GH) is crucial to growth and development

Studies have shown that TMAO is an independent risk factor for the occurrence of malignant adverse cardiovascular events, but whether it is harmful or beneficial to patients with cardiovascular diseases with mild or no clinical manifestations remains controversial

Only L-carnitine is active in the body and represents the form that occurs in food

doi: 10.1038/s41577-020-0402-6 42 ChumakovK.AvidanM